Science ❯ Medical Research ❯ Clinical Trials

Drug Efficacy

Health Outcomes Neurological Disorders Weight Loss Treatments GLP-1 Receptor Agonists GLP-1 Research Cardiovascular Disease Research HIV Research Public Health Alzheimer's Research HIV Treatment Innovations Safety Assessments GLP-1 Injections Neuroscience Preventive Medicine Weight Loss Mechanisms Long-acting Treatments

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Lilly’s premium price meets a new oral challenger in the GLP‑1 race.

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler